Clinical Trials Browser

Phase 2 × INDUSTRY × duvelisib × Clear all

NCT03372057 2025-03-07

PRIMO

Phase 2 Completed

156 enrolled 21 charts

Lymphoma, Recurrence, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

NCT02711852 2023-09-11

A Long-term, Continued Treatment and Follow-up Study in Participants With Hematologic Malignancies Treated With Duvelisib (IPI-145)

Phase 2 Completed

19 enrolled 11 charts

Other hematologic neoplasm

Hematologic Neoplasms

NCT03370185 2023-02-28

BRIO

Phase 2 Withdrawn

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell

NCT02605694 2021-03-17

FRESCO

Phase 2 Withdrawn

Lymphoma

NCT04707079 2021-01-13

A Safety and Efficacy Study of Duvelisib in Relapsed/Refractory Follicular Lymphoma

Phase 2 Unknown

Lymphoma, Follicular